Solid tumour vaccine (Northwest Biotherapeutics)

N/A

Report date: 2024/11/18 20:00:28

Base Information

Drug NameSolid tumour vaccine (Northwest Biotherapeutics)

Drug Alias NameDCVax (Head & Neck)DCVax (Direct adjuvant cancer therapy)DCVax (Pancreas)DCVax (Direct)DCVax (Liver) +[7]

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsBrain metastasesMetastatic breast cancerNeoplasm Metastasis +[9]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNorthwest Biotherapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNorthwest Biotherapeutics Inc

Active IndicationsN/A

Inactive IndicationsBrain metastasesMetastatic breast cancerNeoplasm Metastasis +[9]

Other Information

ATC CodeN/A